Importer of Controlled Substances Application: Lonza Tampa, LLC, 9735 [2025-02737]
Download as PDF
Federal Register / Vol. 90, No. 31 / Tuesday, February 18, 2025 / Notices
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–02737 Filed 2–14–25; 8:45 am]
Docket: To read or download
comments or other material in the
docket, go to https://
www.regulations.gov. Documents in the
docket are listed in the https://
www.regulations.gov index; however,
some information (e.g., copyrighted
material) is not publicly available to
read or download through the website.
All submissions, including copyrighted
material, are available for inspection
through the OSHA Docket Office.
Contact the OSHA Docket Office at (202)
693–2350 (TTY (877) 889–5627) for
assistance in locating docket
submissions.
Instructions: All submissions must
include the agency name and the OSHA
docket number (OSHA–2012–0031) for
the Information Collection Request
(ICR). OSHA will place comments,
including personal information, in the
public docket, which may be available
online. Therefore, OSHA cautions
interested parties about submitting
personal information such as social
security number and date of birth.
For further information on submitting
comments, see the ‘‘Public
Participation’’ heading in the section of
this notice titled SUPPLEMENTARY
BILLING CODE P
INFORMATION
is notice that on February 4, 2025,
Lonza Tampa, LLC, 4901 West Grace
Street, Tampa, Florida 33607–3805,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
[FR Doc. 2025–02731 Filed 2–14–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Schedule
[Docket No. DEA–1497]
Psilocybin ......................
Importer of Controlled Substances
Application: Lonza Tampa, LLC
The company plans to import drug
code 7437 (Psilocybin) as bulk active
pharmaceutical ingredient and as
finished dosage units for clinical trials,
research, and analytical purposes. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Lonza Tampa, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 20, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 20, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Drug
code
Controlled substance
Drug Enforcement Administration
VerDate Sep<11>2014
17:15 Feb 14, 2025
Jkt 265001
9735
7437
I
Matthew Strait,
Deputy Assistant Administrator.
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2012–0031]
Seleda Perryman, Directorate of
Standards and Guidance, OSHA, U.S.
Department of Labor, telephone (202)
693–2222.
SUPPLEMENTARY INFORMATION:
I. Background
The Department of Labor, as part of
the continuing effort to reduce
paperwork and respondent (i.e.,
employer) burden, conducts a
preclearance consultation program to
provide the public with an opportunity
AGENCY: Occupational Safety and Health to comment on proposed and
continuing information collection
Administration, Labor.
requirements in accordance with the
ACTION: Request for public comment.
Paperwork Reduction Act of 1995 (PRA)
SUMMARY: OSHA solicits public
(44 U.S.C. 3506(c)(2)(A)). This program
comments concerning the proposal to
ensures that information is in the
extend the Office of Management and
desired format, reporting burden (time
Budget’s (OMB) approval of the
and costs) is minimal, collection
information collection requirements
instruments are clearly understood, and
specified in the 4, 4′-Methylenedianiline OSHA’s estimate of the information
(MDA) in Construction Standard.
collection burden is accurate. The
DATES: Comments must be submitted
Occupational Safety and Health Act of
(postmarked, sent, or received) by April 1970 (OSH Act) (29 U.S.C. 651 et seq.)
21, 2025.
authorizes information collection by
employers as necessary or appropriate
ADDRESSES:
Electronically: You may submit
for enforcement of the OSH Act or for
comments, including attachments,
developing information regarding the
electronically at https://
causes and prevention of occupational
www.regulations.gov, which is the
injuries, illnesses, and incidents (29
Federal eRulemaking Portal. Follow the U.S.C. 657). The OSH Act also requires
instructions online for submitting
that OSHA obtain such information
comments.
with minimum burden upon employers,
4, 4′-Methylenedianiline (MDA) in
Construction Standard; Extension of
the Office of Management and
Budget’s (OMB) Approval of
Information Collection (Paperwork)
Requirements
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\18FEN1.SGM
18FEN1
Agencies
[Federal Register Volume 90, Number 31 (Tuesday, February 18, 2025)]
[Notices]
[Page 9735]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02737]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1497]
Importer of Controlled Substances Application: Lonza Tampa, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Lonza Tampa, LLC has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 20, 2025. Such persons may also file a written request for a
hearing on the application on or before March 20, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 4, 2025, Lonza Tampa, LLC, 4901 West Grace
Street, Tampa, Florida 33607-3805, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Psilocybin............................. 7437 I
------------------------------------------------------------------------
The company plans to import drug code 7437 (Psilocybin) as bulk
active pharmaceutical ingredient and as finished dosage units for
clinical trials, research, and analytical purposes. No other activity
for this drug code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-02737 Filed 2-14-25; 8:45 am]
BILLING CODE P